All SARS-CoV-2 articles – Page 19
-
NewsNew SARS-CoV-2 variant Eris on the rise
The EG.5 lineage of SARS-CoV-2, known as Eris, which has been spreading globally, has been found to be able to escape neutralizing antibodies better than other currently circulating SARS-CoV-2 lineages.
-
NewsScientists uncover COVID’s weakness - the need for human cells
New UC Riverside research has revealed COVID’s Achilles heel — its dependence on key human proteins for its replication — which can be used to prevent the virus from making people sick.
-
NewsMore people develop sepsis than we thought — but more survive
The observed increase in cases is largely due to more people developing sepsis repeatedly, rather than dying the first time they contract it, a new study reveals.
-
NewsRapid acting oral vaccines are on the way
Researchers studying SARS-CoV-2 may have developed new methods to administer vaccines orally, which would be both easier to administer and more effective at combatting illnesses.
-
CareersNew research IDs 28 genetic regions linked to susceptibility and severity of COVID-19
A study identifies 51 significant genome-wide loci associated with both COVID-19 severity and SARS-CoV-2 susceptibility, providing valuable information about the disease.
-
NewsMap the coronavirus spike protein for insight into vaccine development
A new study has found that the fusion peptide in the spike protein plays a more invasive role in fusing the virus to the cell than previously thought, which is significant in understanding how infection occurs.
-
NewsStudy helps explain SARS-CoV-2 variants’ rapid spread
Omicron variants, which circulated quickly around the globe, bind to cells more avidly and evade antibodies more efficiently than earlier variants, new research reveals.
-
NewsTexas Biomed partners with Scancell to test novel COVID vaccine
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed).
-
NewsAttack on Mac1 Covid protein may lead to longer lasting live-attenuated vaccine
Research could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.
-
NewsN-protein research reveals role of human body temperature in Covid proliferation
Researchers shed light on a pivotal part in the RNA-binding mechanism of the nucleocapsid protein (N) – SARS-CoV-2 probably uses human body temperature for its proliferation strategy.
-
NewsCommon cold virus exposure may help usher in immunity to Covid
Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study.
-
NewsMolnupiravir dose of human effect size-equivalent blocks Covid transmission in ferrets
Two oral drugs provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose.
-
NewsModulating type 1 Interferon may expand treatment options for COVID-19
Researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body’s initial defenses against infection, impacts SARS-CoV-2 viral replication and disease progression.
-
NewsNew Drosophila toolkit to help reveal how Covid-19 virus impacts human health
Researchers have developed a toolkit of <i>Drosophila melanogaster</i> COVID-19 resources to study how viral and human proteins interact, with the goal of developing therapies for symptoms caused by existing and new strains.
-
NewsModerna is safest, most effective mRNA vaccine against COVID-19 for older adults
A study of older US adults found that the risk of negative effects of both mRNA vaccines is exceptionally low, but lowest with the Moderna vaccine.
-
NewsAI-based wastewater sampling predicts COVID hospital admissions
Researchers have developed an accurate prediction tool for estimating COVID-19 hospital admissions, using an Artificial Intelligence (AI) based system with wastewater sampling.
-
NewsBreath test rapidly detects COVID-19 virus
Scientists have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.
-
NewsCOVID-19 vaccination reduces severity and mortality after breakthrough infections
Among individuals recently infected with SARS-CoV-2, those who were fully vaccinated had lower concentrations of almost all inflammation markers (cytokines and chemokines) than those who were unvaccinated in the short-term and long-term after symptomatic SARS-CoV-2 infection.
-
NewsNewly discovered antibodies can neutralize COVID-19 variants
Scientists have isolated potent neutralizing antibodies from a COVID-19 vaccinated SARS survivor that exhibited remarkable breadth against known sarbecoviruses.
-
NewsSmaller magnetic beads with superior magnetic moment capture Covid virus more quickly
Scientists have developed a more efficient way to test SARS-CoV-2 Virus with a novel nano-immune magnetic bead (Mal-IMB) that can efficiently be bound to the pseudovirus in the study of protein biomimetic mineralization and synthesized into magnetic nanoparticles.